Discover the range of academic oncology titles at Springer Nature here.
CAHON: Stop hate crimes and racism
The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond.
Articles
-
-
Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
-
LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL
-
Key regulators of sensitivity to immunomodulatory drugs in cancer treatment
-
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma
-
The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer
-
Metabolomic analyses for atherosclerosis, diabetes, and obesity
-
Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases
-
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies
-
Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy
Springer Nature Oncology Portfolio
Editors-in-Chief
Chung-Tsen Hsueh, Loma Linda University
Delong Liu, New York Medical College
Aims and scope
Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines. Read more.
Announcing the launch of In Review
Biomarker Research, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Follow
Annual Journal Metrics
-
Speed
30 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
72 days from submission to acceptance
15 days from acceptance to publicationCitation Impact
4.866 - 2-year Impact Factor
1.068 - Source Normalized Impact per Paper (SNIP)
1.298 - SCImago Journal Rank (SJR)
Usage
235,112 Downloads
73 Altmetric mentions
On the blog
-
Screening for kidney cancer in Leeds
16 April 2021
-
-
MIRRORS: robotic surgery for advanced ovarian cancer
19 February 2021
